Keyphrases
Childhood Cancer
100%
Tinnitus
90%
Cisplatin-induced Hearing Loss
90%
Allelic Variation
90%
Questionnaire Survey
90%
Childhood Cancer Survivors
90%
Dutch
90%
Risk Factors
90%
Children with Cancer
90%
Cisplatin
72%
Cultured Human Cells
45%
Pathophysiological Basis
45%
Cellular Response
45%
Combined Cohort
45%
Cisplatin-induced
45%
Cytokine Toxicity
45%
Ototoxicity
45%
Genetic Basis
45%
Genetic Susceptibility
45%
Cisplatin Ototoxicity
45%
Hearing Impairment
45%
Cytokine Secretion
45%
Genetic Variants
45%
Odds Ratio
45%
Genome-wide Association Study
45%
Confidence Interval
45%
Total Body Irradiation
27%
Cranial Irradiation
27%
Ear Nose Throat
27%
Survivors
18%
Health Questionnaire
9%
Treatment Factors
9%
Occurrence Factor
9%
One Percent
9%
Previously Treated
9%
Self-reported Health
9%
Patient Characteristics
9%
Oncology
9%
Cumulative Dose
9%
Childhood Cancer Treatment
9%
Multivariate Logistic Regression Model
9%
Patient Treatment
9%
Age at Diagnosis
9%
Late Effects
9%
National Cohort
9%
Nursing and Health Professions
Tinnitus
90%
Childhood Cancer
90%
Odds Ratio
41%
Confidence Interval
41%
Skull Irradiation
24%
Ear Nose Throat Surgery
24%
Cisplatin
24%
Whole Body Radiation
24%
Cancer Therapy
8%
Logistic Regression Analysis
8%
Medicine and Dentistry
Tinnitus
90%
Childhood Cancer
90%
Odds Ratio
41%
Ear Nose Throat Surgery
24%
Skull Irradiation
24%
Whole Body Radiation
24%
Cisplatin
24%
Patient Characteristics
8%
Oncology
8%
Late Effect
8%
Awareness
8%
Logistic Regression Analysis
8%
Cancer Therapy
8%
